Updated: Feb 18, 2021
The Ksmart® SARS COV-2 Antigen test is now listed among the ones authorized by French ANSM, i.e. “Agence nationale de sécurité du médicament et des produits de santé” (see https://covid-19.sante.gouv.fr/tests official website for details). This authorization for France follows recent registration in Germany, Italy and in Czech Republic, confirming that the solution manufactured by AVALUN for COVID Antigen testing matches the highest required standards.
About the Ksmart® SARS COV-2 Antigen test
The Ksmart® SARS-COV2 Antigen Rapid Test is a qualitative membrane-based immunoassay for the detection of 2019-nCoV antigens assay for use with the LabPad® Evolution at the Point-of-Care. The automated LabPad® Evolution non operator dependent reading increases throughput with result available within 5 to maximum 20 minutes at the Point-of Care and allows for automatic reporting.